Home Newsfeeds ArcelorMittal Boosts Annual Base Dividend To Shareholders To $0.44 Per Share, Up From $0.38 Per Share

ArcelorMittal Boosts Annual Base Dividend To Shareholders To $0.44 Per Share, Up From $0.38 Per Share

The Board proposes to increase the annual base dividend to shareholders to $0.44/sh (to be paid in 2 equal instalments in June 2023 and December 2023), subject to the approval of shareholders at the 2023 AGM.

byBenzinga Newsdesk

February 9, 2023

1 minute read

The Board proposes to increase the annual base dividend to shareholders to $0.44/sh (to be paid in 2 equal instalments in June 2023 and December 2023), subject to the approval of shareholders at the 2023 AGM.

Best-Owner Mindset – IFF Divests Cosmetic Ingredients Business To Swiss Chemical Company Clariant For $810M

By Shivani Kumaresan

October 30, 6:23 AM

International Flavors & Fragrances Inc (NYSE: IFF) said specialty chemical company Clariant AG (OTC: CLZNF) has agreed to acquire its

CLZNF

Jaguar Health Announces FDA Activation Of Third-Party Investigational New Drug Application For Evaluation Of Crofelemer For Treatment Of Uncontrolled Diarrhea In Patient With Short Bowel Syndrome

By Happy Mohamed

August 1, 8:49 AM

Napo Pharmaceuticals, a Jaguar Health company and the manufacturer of crofelemer, is supporting this physician-generated IND SAN FRANCISCO, CA / ACCESSWIRE / August 1, 2023 / Jaguar Health (NASDAQ:JAGX) ("the

JAGX

U.S. House Transportation Committee To Hold Feb. 1 Hearing On Infrastructure, Supply Chain Issues With Railroads, Trucking Groups

By Benzinga Newsdesk

January 26, 11:16 AM

- Statement

EXCLUSIVE: Hashing Out The Trailblazing Journey Of Roger Volodarsky And Puffco

By Nicolas Jose Rodriguez

March 13, 8:41 AM

The story of Puffco is the story of a man, his time and place, his passion for hashish, and a team of creatives pushing his company forward. And it all started as a hobby when Vape pens set the scene in New York in 2012.

AAPL

ArcelorMittal Boosts Annual Base Dividend To Shareholders To $0.44 Per Share, Up From $0.38 Per Share

Related Posts

Best-Owner Mindset – IFF Divests Cosmetic Ingredients Business To Swiss Chemical Company Clariant For $810M

Jaguar Health Announces FDA Activation Of Third-Party Investigational New Drug Application For Evaluation Of Crofelemer For Treatment Of Uncontrolled Diarrhea In Patient With Short Bowel Syndrome

U.S. House Transportation Committee To Hold Feb. 1 Hearing On Infrastructure, Supply Chain Issues With Railroads, Trucking Groups

EXCLUSIVE: Hashing Out The Trailblazing Journey Of Roger Volodarsky And Puffco